Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dopaminergic modulation of visual sensitivity in man

Identifieur interne : 001A04 ( PascalFrancis/Corpus ); précédent : 001A03; suivant : 001A05

Dopaminergic modulation of visual sensitivity in man

Auteurs : G. Masson ; D. Mestre ; O. Blin

Source :

RBID : Pascal:94-0009213

Descripteurs français

English descriptors

Abstract

A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0767-3981
A02 01      @0 FCPHEZ
A03   1    @0 Fundam. clin. pharmacol.
A05       @2 7
A06       @2 8
A08 01  1  ENG  @1 Dopaminergic modulation of visual sensitivity in man
A11 01  1    @1 MASSON (G.)
A11 02  1    @1 MESTRE (D.)
A11 03  1    @1 BLIN (O.)
A14 01      @1 CNRS Univ. Aix-Marseille II, cognition mouvement @2 13388 Marseille @3 FRA
A14 02      @1 CHU Timone, pharmacologie médicale clin., cent. pharmacologie clin. évaluation thérapeutique @2 13385 Marseille @3 FRA @Z 3 aut.
A20       @1 449-463
A21       @1 1993
A23 01      @0 ENG
A43 01      @1 INIST @2 14711 @5 354000048284230070
A44       @0 0000
A45       @0 3 p.
A47 01  1    @0 94-0009213
A60       @1 P
A61       @0 A
A64 01  1    @0 Fundamental and clinical pharmacology
A66 01      @0 FRA
C01 01    ENG  @0 A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man
C02 01  X    @0 002A25I
C03 01  X  FRE  @0 Transmission dopaminergique @5 01
C03 01  X  ENG  @0 Dopaminergic transmission @5 01
C03 01  X  SPA  @0 Transmisión dopaminérgica @5 01
C03 02  X  FRE  @0 Dopamine @2 NK @2 FR @5 04
C03 02  X  ENG  @0 Dopamine @2 NK @2 FR @5 04
C03 02  X  SPA  @0 Dopamina @2 NK @2 FR @5 04
C03 03  X  FRE  @0 Apomorphine @2 NK @2 FR @5 07
C03 04  X  FRE  @0 Parkinson maladie @2 NM @5 10
C03 04  X  ENG  @0 Parkinson disease @2 NM @5 10
C03 04  X  SPA  @0 Parkinson enfermedad @2 NM @5 10
C03 05  X  FRE  @0 Vision @5 13
C03 05  X  ENG  @0 Vision @5 13
C03 05  X  SPA  @0 Visión @5 13
C03 06  X  FRE  @0 Oeil @5 16
C03 06  X  ENG  @0 Eye @5 16
C03 06  X  SPA  @0 Ojo @5 16
C07 01  X  FRE  @0 Appareil visuel @5 14
C07 01  X  ENG  @0 Visual system @5 14
C07 01  X  SPA  @0 Aparato visual @5 14
C07 02  X  FRE  @0 Système nerveux pathologie @5 61
C07 02  X  ENG  @0 Nervous system diseases @5 61
C07 02  X  SPA  @0 Sistema nervioso patología @5 61
C07 03  X  FRE  @0 Système nerveux central pathologie @5 62
C07 03  X  ENG  @0 Central nervous system disease @5 62
C07 03  X  SPA  @0 Sistema nervosio central patología @5 62
C07 04  X  FRE  @0 Encéphale pathologie @5 63
C07 04  X  ENG  @0 Cerebral disorder @5 63
C07 04  X  SPA  @0 Encéfalo patología @5 63
C07 05  X  FRE  @0 Extrapyramidal syndrome @5 64
C07 05  X  ENG  @0 Extrapyramidal syndrome @5 64
C07 05  X  SPA  @0 Extrapiramidal síndrome @5 64
C07 06  X  FRE  @0 Maladie dégénérative @5 65
C07 06  X  ENG  @0 Degenerative disease @5 65
C07 06  X  SPA  @0 Enfermedad degenerativa @5 65
N21       @1 006

Format Inist (serveur)

NO : PASCAL 94-0009213 INIST
ET : Dopaminergic modulation of visual sensitivity in man
AU : MASSON (G.); MESTRE (D.); BLIN (O.)
AF : CNRS Univ. Aix-Marseille II, cognition mouvement/13388 Marseille/France; CHU Timone, pharmacologie médicale clin., cent. pharmacologie clin. évaluation thérapeutique/13385 Marseille/France (3 aut.)
DT : Publication en série; Niveau analytique
SO : Fundamental and clinical pharmacology; ISSN 0767-3981; Coden FCPHEZ; France; Da. 1993; Vol. 7; No. 8; Pp. 449-463; Bibl. 3 p.
LA : Anglais
EA : A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man
CC : 002A25I
FD : Transmission dopaminergique; Dopamine; Apomorphine; Parkinson maladie; Vision; Oeil
FG : Appareil visuel; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Dopaminergic transmission; Dopamine; Parkinson disease; Vision; Eye
EG : Visual system; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD : Transmisión dopaminérgica; Dopamina; Parkinson enfermedad; Visión; Ojo
LO : INIST-14711.354000048284230070
ID : 94-0009213

Links to Exploration step

Pascal:94-0009213

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Dopaminergic modulation of visual sensitivity in man</title>
<author>
<name sortKey="Masson, G" sort="Masson, G" uniqKey="Masson G" first="G." last="Masson">G. Masson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, cognition mouvement</s1>
<s2>13388 Marseille</s2>
<s3>FRA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mestre, D" sort="Mestre, D" uniqKey="Mestre D" first="D." last="Mestre">D. Mestre</name>
</author>
<author>
<name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">94-0009213</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 94-0009213 INIST</idno>
<idno type="RBID">Pascal:94-0009213</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001A04</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Dopaminergic modulation of visual sensitivity in man</title>
<author>
<name sortKey="Masson, G" sort="Masson, G" uniqKey="Masson G" first="G." last="Masson">G. Masson</name>
<affiliation>
<inist:fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, cognition mouvement</s1>
<s2>13388 Marseille</s2>
<s3>FRA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mestre, D" sort="Mestre, D" uniqKey="Mestre D" first="D." last="Mestre">D. Mestre</name>
</author>
<author>
<name sortKey="Blin, O" sort="Blin, O" uniqKey="Blin O" first="O." last="Blin">O. Blin</name>
</author>
</analytic>
<series>
<title level="j" type="main">Fundamental and clinical pharmacology</title>
<title level="j" type="abbreviated">Fundam. clin. pharmacol.</title>
<idno type="ISSN">0767-3981</idno>
<imprint>
<date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Fundamental and clinical pharmacology</title>
<title level="j" type="abbreviated">Fundam. clin. pharmacol.</title>
<idno type="ISSN">0767-3981</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Dopamine</term>
<term>Dopaminergic transmission</term>
<term>Eye</term>
<term>Parkinson disease</term>
<term>Vision</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Transmission dopaminergique</term>
<term>Dopamine</term>
<term>Apomorphine</term>
<term>Parkinson maladie</term>
<term>Vision</term>
<term>Oeil</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0767-3981</s0>
</fA01>
<fA02 i1="01">
<s0>FCPHEZ</s0>
</fA02>
<fA03 i2="1">
<s0>Fundam. clin. pharmacol.</s0>
</fA03>
<fA05>
<s2>7</s2>
</fA05>
<fA06>
<s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Dopaminergic modulation of visual sensitivity in man</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MASSON (G.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MESTRE (D.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BLIN (O.)</s1>
</fA11>
<fA14 i1="01">
<s1>CNRS Univ. Aix-Marseille II, cognition mouvement</s1>
<s2>13388 Marseille</s2>
<s3>FRA</s3>
</fA14>
<fA14 i1="02">
<s1>CHU Timone, pharmacologie médicale clin., cent. pharmacologie clin. évaluation thérapeutique</s1>
<s2>13385 Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>449-463</s1>
</fA20>
<fA21>
<s1>1993</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>14711</s2>
<s5>354000048284230070</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>3 p.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>94-0009213</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Fundamental and clinical pharmacology</s0>
</fA64>
<fA66 i1="01">
<s0>FRA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A25I</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Transmission dopaminergique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dopaminergic transmission</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Transmisión dopaminérgica</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Vision</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Vision</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Visión</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Oeil</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Eye</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Ojo</s0>
<s5>16</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Appareil visuel</s0>
<s5>14</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Visual system</s0>
<s5>14</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Aparato visual</s0>
<s5>14</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21>
<s1>006</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 94-0009213 INIST</NO>
<ET>Dopaminergic modulation of visual sensitivity in man</ET>
<AU>MASSON (G.); MESTRE (D.); BLIN (O.)</AU>
<AF>CNRS Univ. Aix-Marseille II, cognition mouvement/13388 Marseille/France; CHU Timone, pharmacologie médicale clin., cent. pharmacologie clin. évaluation thérapeutique/13385 Marseille/France (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Fundamental and clinical pharmacology; ISSN 0767-3981; Coden FCPHEZ; France; Da. 1993; Vol. 7; No. 8; Pp. 449-463; Bibl. 3 p.</SO>
<LA>Anglais</LA>
<EA>A large body of experimental evidence supports the hypothesis that dopamine is a functional neuromodulator at many levels of the visual system. Intrinsic dopaminergic neurons were characterized in most mammalian retina, including man. These neurons give rise to a dendritic plexus covering the retina. Thus, dopamine seems to be involved in the organization of the ganglion cell and the bipolar cell receptive fields and modulates physiological activity of photoreceptors, both processes which underlie sensitivity and spatial selectivity of visual processing in the early stage of the visual system. Moreover, few data are now available concerning the functional significance of dopaminergic modulation of visual sensitivity in man</EA>
<CC>002A25I</CC>
<FD>Transmission dopaminergique; Dopamine; Apomorphine; Parkinson maladie; Vision; Oeil</FD>
<FG>Appareil visuel; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Dopaminergic transmission; Dopamine; Parkinson disease; Vision; Eye</ED>
<EG>Visual system; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Transmisión dopaminérgica; Dopamina; Parkinson enfermedad; Visión; Ojo</SD>
<LO>INIST-14711.354000048284230070</LO>
<ID>94-0009213</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A04 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001A04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:94-0009213
   |texte=   Dopaminergic modulation of visual sensitivity in man
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024